
Once again
Zydus Animal Health and Investments limited has retained its crown in 2018 for the Animal Pharm Award- “Best Company in India, Middle East, Africa. It has been the 3rd Animal Pharm Award in the last 4 years. Earlier, Zydus had also received 3 national awards for being the Best Poultry Company & the Best Animal Pharma Company.
Zydus Animal Health and Investments limited (Zydus AHL), a division of Cadila Healthcare Ltd is headquartered at Ahmedabad, India. Zydus AHL is one of the leading players in the Indian veterinary formulations market having the most comprehensive range of products in all major therapeutic segments to cater to the varied demand of Large & Small Ruminants, Poultry, Pigs, Equines and Companion Animals.
Zydus maintains highest standards in its product offerings and ensures innovative solutions through continued improvement in its operations. A wide range of capabilities have helped Zydus Animal Health and Investments limited to create a robust manufacturing infrastructure. The firm has a state-of-the-art WHO- GMP compliant plant in Haridwar for manufacturing powders, tablets, liquid and injectables. Recently, the plant has cleared the audit of Saudi Arabia regulatory authority.
Zydus’ dedicated probiotic manufacturing plant at Ahmedabad is also expanding its reach to cater for Indian and international veterinary probiotic markets.
Backed by Pharmaceutical Technology Centre of Zydus with more than 400 scientists, Zydus AHL has an unmatched record of introducing large number of new products for the first time in the country. In 2018, Zydus introduced six new products to strengthen its food animal portfolio. The company received Indian approval for two poultry vaccines, as well as 26 marketing authorizations from south-east Asia, Africa and the Middle East.
The company keeps on exploring newer opportunities to expand its market reach year after year and has current turnover in excess of INR 500 Crore. Going forward, export will be a major growth driver for Zydus.